(Q39940402)

15 September 2017

title

Identification of a neutralization epitope in the VP1 capsid protein of SV40. (English)

1 reference

15 September 2017

Haruhiko Murata

1

1 reference

15 September 2017

Belete Teferedegne

2

1 reference

15 September 2017

Li Sheng

3

1 reference

15 September 2017

Andrew M Lewis

4

1 reference

15 September 2017

Keith Peden

5

1 reference

15 September 2017

language of work or name

English

0 references

publication date

11 September 2008

1 reference

15 September 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

Virology

1 reference

15 September 2017

volume

381

1 reference

15 September 2017

issue

1

1 reference

15 September 2017

page(s)

116-122

1 reference

Identification of a third human polyomavirus

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.032

Lack of Serologic Evidence for Prevalent Simian Virus 40 Infection in Humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.032

Interaction of polyomavirus internal protein VP2 with the major capsid protein VP1 and implications for participation of VP2 in viral entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.032

Some oral poliovirus vaccines were contaminated with infectious SV40 after 1961.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.032

Clonal integration of a polyomavirus in human Merkel cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.032

Identification of a novel polyomavirus from patients with acute respiratory tract infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.032

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.032

Selective extraction of polyoma DNA from infected mouse cell cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.032

BK virus antigenic variants: sequence analysis within the capsid VP1 epitope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.032

SV40 pseudovirions as highly efficient vectors for gene transfer and their potential application in cancer therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.032

Serological typing scheme for BK-like isolates of human polyomavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.032

Structure of simian virus 40 at 3.8-A resolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.032

Studies of neutralising antibodies to SV40 in human sera

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.032

Identification of a mutation in the SV40 capsid protein VP1 that influences plaque morphology, vacuolization, and receptor usage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.032

Isolation of Mutants of an Animal Virus in Bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.032

Is there a role for SV40 in human cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.032

Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.032

Advances in the biology of JC virus and induction of progressive multifocal leukoencephalopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.032

Simian virus 40 (SV40) and human cancer: a review of the serological data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.032

The structure of simian virus 40 refined at 3.1 A resolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.032

What they are, how they work and why they do what they do? The story of SV40-derived gene therapy vectors and what they have to offer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.032

Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.032

The vacuolating virus, S.V. 40

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.032

Gangliosides are receptors for murine polyoma virus and SV40

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.032

Serological cross-reactivities between antibodies to simian virus 40, BK virus, and JC virus assessed by virus-like-particle-based enzyme immunoassays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.032

10.1016/J.VIROL.2008.07.032

7 January 2021

Identifiers

DOI

1 reference

15 September 2017

1 reference